...
首页> 外文期刊>Journal of Clinical Microbiology >Buffered Plate Antigen Test as a Screening Test for Diagnosis of Human Brucellosis
【24h】

Buffered Plate Antigen Test as a Screening Test for Diagnosis of Human Brucellosis

机译:缓冲板抗原测试作为人类布鲁氏菌病诊断的筛选测试

获取原文
           

摘要

Brucellosis in Argentina is currently investigated in bank donor blood by the standard plate agglutination test (PAT). This study evaluated the buffered plate antigen test (BPA), now used to screen for bovine brucellosis, as a screen for human disease. Of 57 sera from patients with culture-confirmed brucellosis, 100% were detected with the BPA. Of 142 sera positive by rose bengal (RB) and complement fixation (CF), from patients with clinical evidence of brucellosis, the BPA detected 100%. Of 307 sera from a nonsymptomatic population that were RB and CF negative, the BPA detected 99.67% of the negative sera. The data indicate that the BPA is satisfactory compared to the other agglutination tests employed. It is an inexpensive and practical screening test and reduces the nonspecific reactions detected by the PAT.
机译:目前,阿根廷的布鲁氏菌病已通过标准平板凝集试验(PAT)在银行供血中进行了调查。这项研究评估了目前用于筛查牛布鲁氏菌病的缓冲板抗原测试(BPA),作为人类疾病的筛查。在培养确诊的布鲁氏菌病患者的57份血清中,用BPA检测到100%。在有布鲁氏菌病临床证据的患者中,经玫瑰孟加拉(RB)和补体固定(CF)检出的142份阳性血清中,BPA检测出100%。在非症状人群的RB和CF阴性的307份血清中,BPA检测到了99.67%的阴性血清。数据表明,与采用的其他凝集试验相比,BPA令人满意。这是一种廉价且实用的筛选测试,可减少PAT检测到的非特异性反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号